Pure Global

Parvovirus B19 IgG ELISA - India CDSCO Medical Device Registration

Parvovirus B19 IgG ELISA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000101_95ebb1003ee387af1850e01420d3a7d2_b367b0ff26348a16da6821461ec28b80. This device is marketed under the brand name NovaLisa. The license holder is Dia Sure Immunodiagnostic LLP, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Parvovirus B19 IgG ELISA
UID: IMP/IVD/2021/000101_95ebb1003ee387af1850e01420d3a7d2_b367b0ff26348a16da6821461ec28b80

Brand Name

NovaLisa

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Parvovirus B19 IgG ELISA is intended for the qualitative determination of IgG class antibodies against Parvovirus B19 in human serum or plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing